retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: (Q46761542)
Jump to navigation
Jump to search
scientific article published in October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: |
scientific article published in October 2005 |
Statements
1 reference
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: (English)
1 reference
Bent Ejlertsen
1 reference
Ann S Knoop
1 reference
Helle Knudsen
1 reference
Eva Balslev
1 reference
Birgitte B Rasmussen
1 reference
Jens Overgaard
1 reference
Kirsten V Nielsen
1 reference
Andreas Schonau
1 reference
KatrÃn Gunnarsdóttir
1 reference
Karen E Olsen
1 reference
Henning Mouridsen
1 reference
Danish Breast Cancer Cooperative Group
1 reference
1 October 2005
1 reference
1 reference
23
1 reference
7483-7490
1 reference
30
1 reference
Identifiers
1 reference
1 reference